Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium [Phase 4]

View source ↗

Summary

Phase 4 clinical trial at Kasr El Aini Hospital is recruiting to compare dexmedetomidine–midazolam with ketamine–midazolam for emergence delirium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Ketamine (ketamine)
  • Midazolam (Midazolam)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Emergence Delirium | Phase 4 | Status: RECRUITING